HRTX

Heron Therapeautics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Heron Therapeautics Inc HRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 10.25 20:00:00
Open Price Low Price High Price Close Price Prev Close
10.25
more quote information »

Recent News

Date Time Source Heading
10/15/202116:27EDGARStatement of Changes in Beneficial Ownership (4)
10/15/202116:25EDGARStatement of Changes in Beneficial Ownership (4)
10/15/202116:24EDGARStatement of Changes in Beneficial Ownership (4)
10/04/202108:40EDGARCurrent Report Filing (8-k)
10/04/202108:30PRNUSHeron Therapeutics Announces Filing of a Supplemental New..
9/29/202116:17EDGARInitial Statement of Beneficial Ownership (3)
9/24/202108:30EDGARCurrent Report Filing (8-k)
9/23/202116:29EDGARStatement of Changes in Beneficial Ownership (4)
9/21/202116:05PRNUSHeron Therapeutics to Present at the 2021 Cantor Virtual..
9/13/202119:33TRMN2 “Strong Buy” Stocks With Heavy Short Interest
8/09/202108:16EDGARQuarterly Report (10-q)
8/09/202108:11EDGARCurrent Report Filing (8-k)
8/09/202108:00PRNUSHeron Therapeutics Announces Financial Results for the Three..
8/02/202116:32EDGARCurrent Report Filing (8-k)
7/28/202116:05PRNUSHeron Therapeutics Announces Publication of Results from..
7/21/202116:29SEEKHeron Therapeutics highlights promising data from ZYNRELEF..
7/21/202116:05PRNUSHeron Therapeutics Announces Publication Showing Reduction..
7/15/202116:53EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202116:50EDGARStatement of Changes in Beneficial Ownership (4)
7/15/202116:47EDGARStatement of Changes in Beneficial Ownership (4)
7/06/202108:30PRNUSHeron Therapeutics Announces 340B Prime Vendor Contract with..
7/01/202109:09SEEKHeron Therapeutics launches ZYNRELEF in the U.S.
7/01/202108:30PRNUSHeron Therapeutics Announces U.S. Commercial Launch and..
6/22/202117:07EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202117:06EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202116:07EDGARCurrent Report Filing (8-k)
5/28/202117:02SEEKHeron Therapeutics files for 12.4M common stock offering..
5/28/202116:20EDGARAutomatic Shelf Registration Statement of Securities of..
5/25/202116:05PRNUSHeron Therapeutics to Present at the 2021 Jefferies Virtual..
5/25/202109:43SEEKHeron Therapeutics completes $150 million convertible debt..
5/25/202109:05EDGARCurrent Report Filing (8-k)
5/25/202109:00PRNUSHeron Therapeutics Announces $150 Million Convertible Debt..
5/13/202108:26EDGARCurrent Report Filing (8-k)
5/13/202108:25SEEKHeron Therapeutics surges on FDA approval for ZYNRELEF
5/13/202108:00PRNUSHeron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™..
5/10/202110:51SEEKHeron Therapeutics climbs on management comments on upcoming..
5/10/202108:46EDGARQuarterly Report (10-q)
5/10/202108:44SEEKHeron Therapeutics EPS misses by $0.03, misses on revenue
5/10/202108:41EDGARCurrent Report Filing (8-k)
5/10/202108:30PRNUSHeron Therapeutics Announces Financial Results for the Three..
5/04/202118:03EDGARStatement of Changes in Beneficial Ownership (4)
4/22/202116:06EDGARProxy Statement (definitive) (def 14a)
4/15/202116:56EDGARStatement of Changes in Beneficial Ownership (4)
4/15/202116:53EDGARStatement of Changes in Beneficial Ownership (4)
4/15/202116:52EDGARStatement of Changes in Beneficial Ownership (4)
3/26/202114:34TRMN2 “Strong Buy” Biotech Stocks With Major Catalysts..
2/24/202108:57SEEKHeron Therapeutics EPS misses by $0.03, beats on revenue
2/24/202108:47EDGARAnnual Report (10-k)
2/24/202108:41EDGARCurrent Report Filing (8-k)
2/24/202108:30PRNUSHeron Therapeutics Announces Financial Results for the Three..
See more news about this stock »
Your Recent History
NASDAQ
HRTX
Heron Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211027 07:17:12